医学影像试剂市场规模、份额、成长分析（按类别、按方式、按技术、按应用、按地区）－2025 年至 2032 年产业预测

2023 年医学影像试剂市场规模价值为 173.5 亿美元，预计将从 2024 年的 182.5 亿美元成长到 2032 年的 273.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.2%。

全球科学成像试剂市场是医疗保健的重要组成部分，为诊断和研究提供必要的工具。这些药剂增强了 MRI、CT、超音波和核子医学等医学影像方式中组织和器官的可见性。主要的市场驱动因素包括慢性病盛行率上升、人口老化以及对准确和早期诊断的需求不断增加。因此，医学影像试剂可以显着提高诊断准确性和治疗计划，改善患者的治疗效果。最近的趋势集中在提供详细功能和代谢资讯的分子成像技术，增加了对可以针对特定分子的先进试剂的需求。此外，混合成像系统的兴起使得需要能够适应多种模式的多功能试剂。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术分析

医学影像试剂市场规模（按类别及复合年增长率）（2025-2032）

• 市场概览
• 显影剂
• 光学试剂
• 核试剂

医学成像试剂市场规模（按模式和复合年增长率）（2025-2032）

• 市场概览
• X射线
• 电脑断层扫描
• 超音波
• 核磁共振扫描

医学成像试剂市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 奈米粒子
• 萤光染料和探针
• 放射性药物
• 萤光蛋白
• 量子点

医学成像试剂市场规模（依应用）及复合年增长率（2025-2032）

• 市场概览
• 诊断
• 药物研发
• 教育研究

医学成像试剂市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• GE Healthcare（USA）
• Siemens Healthineers（Germany）
• Bracco Imaging SpA（Italy）
• Bayer AG（Germany）
• Guerbet Group（France）
• Lantheus Holdings Inc.（USA）
• Jubilant Radiopharma（India）
• Cardinal Health Inc.（USA）
• Nordion（Canada）Inc.（Canada）
• Curium Pharma（France）
• Advanced Accelerator Applications（AAA）-A Novartis Company（Switzerland）
• Eli Lilly and Company（USA）
• Thermo Fisher Scientific Inc.（USA）
• PerkinElmer Inc.（USA）
• Agfa-Gevaert Group（Belgium）
• Merck KGaA（Germany）
• Triad Isotopes Inc.（USA）
• Nihon Medi-Physics Co. Ltd.（Japan）
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.（China）
• EczacIbasI-Monrol Nuclear Products（Turkey）

结论和建议

Medical Imaging Reagents Market size was valued at USD 17.35 billion in 2023 and is poised to grow from USD 18.25 billion in 2024 to USD 27.38 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The global scientific imaging reagents market is a vital component of the healthcare landscape, providing essential tools for diagnostics and research. These reagents enhance the visibility of tissues and organs in medical imaging modalities like MRI, CT, ultrasound, and nuclear medicine. Key market drivers include the rising incidence of chronic illnesses, an aging population, and the increasing need for precise early diagnosis. As a result, medical imaging reagents significantly enhance diagnostic accuracy and treatment planning, improving patient outcomes. Recent trends indicate a growing focus on molecular imaging techniques that offer detailed functional and metabolic information, driving demand for advanced reagents targeting specific molecules. Ongoing R&D efforts aim to create safer, more efficient reagents, while the rise of hybrid imaging systems necessitates versatile reagents adaptable to multiple modalities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Imaging Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Imaging Reagents Market Segments Analysis

Global Medical Imaging Reagents Market is segmented by Class, Modality, Technology, Application and region. Based on Class, the market is segmented into Contrast reagents, Optical reagents and Nuclear reagents. Based on Modality, the market is segmented into X-ray, CT Scan, Ultrasound and MRI Scan. Based on Technology, the market is segmented into Nanoparticles, Fluorescent dyes & probes, Radiopharmaceuticals, Fluorescent proteins and Quantum dots. Based on Application, the market is segmented into Diagnostics, Drug discovery & development and Educational Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Medical Imaging Reagents Market

The rising incidence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has led to an escalating demand for medical imaging procedures. This growing healthcare need places significant importance on medical imaging reagents, which enhance the precision and efficacy of diagnostic imaging techniques. Consequently, their crucial role in facilitating accurate diagnoses is driving increased adoption across healthcare facilities. As the healthcare sector continues to evolve and adapt to the growing prevalence of these health issues, the demand for reliable medical imaging reagents is expected to surge, further supporting advancements in diagnostic technologies and ultimately improving patient outcomes.

Restraints in the Medical Imaging Reagents Market

The Medical Imaging Reagents market faces significant restraints, particularly due to the high costs associated with advanced imaging techniques such as PET and MRI. These expenses not only encompass the reagents themselves but also the necessary equipment and related healthcare services, creating a substantial financial burden for both healthcare facilities and patients. This pricing challenge can hinder market growth, particularly in economically disadvantaged regions where access to such advanced imaging technologies is limited. Consequently, the affordability and overall economic dynamics of the healthcare system are crucial factors influencing the uptake and expansion of medical imaging reagents in various markets.

Market Trends of the Medical Imaging Reagents Market

The Medical Imaging Reagents market is witnessing a robust trend driven by the surging demand for molecular imaging agents, particularly positron emission tomography (PET) and single-photon emission computed tomography (SPECT) radiopharmaceuticals. These innovative reagents facilitate precise visualization and quantification of biological processes at the molecular and cellular levels, proving essential for early disease detection, treatment planning, and monitoring. Significant advancements in the development of radiopharmaceuticals-focused on enhancing specificity and targeting-are further propelling this demand. This trend underscores the healthcare sector's shift towards personalized medicine, with molecular imaging playing a pivotal role in diagnosing and managing complex diseases effectively.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis

Global Medical Imaging Reagents Market Size by Class & CAGR (2025-2032)

• Market Overview
• Contrast reagents
• Optical reagents
• Nuclear reagents

Global Medical Imaging Reagents Market Size by Modality & CAGR (2025-2032)

• Market Overview
• X-ray
• CT Scan
• Ultrasound
• MRI Scan

Global Medical Imaging Reagents Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Nanoparticles
• Fluorescent dyes & probes
• Radiopharmaceuticals
• Fluorescent proteins
• Quantum dots

Global Medical Imaging Reagents Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
• Drug discovery & development
• Educational Research

Global Medical Imaging Reagents Market Size & CAGR (2025-2032)

• North America (Class, Modality, Technology, Application)
  • US
  • Canada
• Europe (Class, Modality, Technology, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Class, Modality, Technology, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Class, Modality, Technology, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Class, Modality, Technology, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Radiopharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion (Canada) Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curium Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Accelerator Applications (AAA) - A Novartis Company (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agfa-Gevaert Group (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triad Isotopes Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Medi-Physics Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EczacIbasI-Monrol Nuclear Products (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations